CVR Energy (CVI) is nearing a deal valued over USD 4bln deal to buy refineries from Marathon Petroleum (MPC), according to WSJ
Newsquawk Staff ·
CVR Energy (CVI) is nearing a deal valued over USD 4bln deal to buy refineries from Marathon Petroleum (MPC), according to WSJ.
What it means
A single-source report of an approaching deal is the standard opening act in refinery M&A coverage: the stock typically gaps on the leak, then trades the gap against confirmation risk until either a formal announcement or a denial. Refining assets change hands with some regularity when integrated majors rationalise downstream footprints, and acquirers of CVI's profile, a standalone refiner with a controlling shareholder known for reshaping portfolios, have historically funded such steps with a mix of debt and equity that re-rates both the balance sheet and the crack-spread sensitivity of the equity. The questions that matter on confirmation are price versus replacement cost and mid-cycle refining EBITDA, the financing structure and any refining partnership drop-down mechanics, and the regulatory path, since consolidating Gulf Coast or Midwest refining capacity has drawn antitrust scrutiny in past episodes. On the sell side, dispositions of this kind have tended to be received as capital-return fuel, with proceeds recycled into buybacks rather than held. The near-term tells are whether the buyer's stock trades up or down on the leak, a rough proxy for how the street reads the multiple, and whether other bidders surface in follow-up reporting. Until an announcement, this remains a rumour-stage move and prior episodes include deals that never closed.
Sources
- Nvidia (NVDA) reportedly orders data centre clients to reduce China exposure, according to FT
- Oracle (ORCL) confirms pricing of USD 10 bln senior notes with maturities from 2029-2046 and prices USD 10bln stock offering at USD 116/shr
- Disney (DIS) eyes thousands of layoffs with managers asked to cut 20%
- Oracle (ORCL) nears a USD 10 bln share sale at 11% discount
- Apple (AAPL) sees Q1 revenue growth of 7%-10% (exp. 6.1%), while it expects 45%-46% gross margin in Q1 (exp. 46.5%)
Related headlines
- Apple (AAPL) received a majority of tariff refunds, while it was also stated that Mac is having an AI moment with Mac Mini and Mac Studio highlighted for local and private AI workloads7 hours ago
- Anthropic investors push for cautious valuation nearer USD 1.5tln, according to WSJ7 hours ago
- Apple (AAPL) Q4 2026 (USD): EPS 2.10 (exp. 1.99), Revenue 114.5bln (exp. 113.4bln); Net income 30.7bln (exp. 29bln); Operating income 35.6bln (exp. 34.6bln); Operating expenses 19.2bln7 hours ago
- ON Semiconductor (ON) Q3 (USD) Adj. EPS 0.90 (exp. 0.88), Revenue 1.72bln (exp. 1.70bln)8 hours ago
- Williams (WMB) Q3 2026 (USD): Adj. EPS 0.54 (exp. 0.54); Adj. EBITDA 2.04bln (exp. 2.03bln)8 hours ago
- Palantir (PLTR) Q3 2026 (USD): Adj. EPS 0.44 (exp. 0.41), Revenue 2.31bln (exp. 2.18bln); Adj. operating income 1.43bln (exp. 1.3bln)8 hours ago
- Roku (ROKU) Q3 2026 (USD): Revenue 1.5bln (exp. 1.41bln); Adj. EBITDA 249mln (exp. 160.6mln); Gross profit 649mln8 hours ago
- Diamondback Energy (FANG) Q3 2026 (USD): Adj. EPS 5.86 (exp. 5.72), Revenue 5.43bln (exp. 4.6bln); Adj. net income 1.65bln (exp. 1.54bln); EPS 5.69; Net income 1.6bln; FCF 2.1bln8 hours ago
- Vertex Pharmaceuticals (VRTX) Q3 (USD) Adj. EPS 4.76 (exp. 4.80), Revenue 3.44bln (exp. 3.42bln)8 hours ago
- [MARKET UPDATE] US indices slide throughout the US afternoon as tech/AI weakness resumes despite optimism on US/Iran diplomacy; NDX -1.3% with the tech sector -2.6%, but RSP +0.75% and majority of sectors gaining, showing positive breadth8 hours ago
- Oracle (ORCL) reportedly sees over USD 10bln demand for its USD 10bln common stock offering10 hours ago
- Edwards Lifesciences (EW) announces that the PASCAL system for tricuspid repair demonstrated superiority compared to medical therapy alone for the six-month primary endpoint of the CLASP II TR trial10 hours ago
- Anthropic (ANT) reportedly said to plan for UK Retail IPO via Retailbook platform alongside US offering11 hours ago
- Edwards Lifesciences (EW) recently weighed following recent progress trial update on TAVR11 hours ago
- Meta (META) eyes at least USD 20bln from a potential US dollar and euro bond sale, Bloomberg reports11 hours ago